6-(4-Benzylpiperazin-1-yl)benzodioxanes as selective ligands at cloned primate dopamine D(4) receptors.

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Bioorganic & Medicinal Chemistry

• Publication date

  2001-12-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/S0968-0896(01)00226-7PMID 11711296
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Current and novel approaches to the drug treatment of schizophrenia.

  2001cited by this paper
• The dopamine D4 receptor: A controversial therapeutic target

  2000cited by this paper
• The Selective Dopamine D4 Receptor Antagonist, PNU-101387G, Prevents Stress-Induced Cognitive Deficits in Monkeys

  2000cited by this paper
• Synthesis of arylpiperazines via palladium-catalysed aromatic amination reactions of bromoarenes with N-tert-butoxycarbonylpiperazine

  1998cited by this paper
• Synthesis of N-arylpiperazines from aryl halides and piperazine under a palladium tri-tert-butylphosphine catalyst

  1998cited by this paper
• 2-Phenyl-4(5)-[[4-(pyrimidin-2-yl)piperazin-1-yl]methyl]imidazole. A highly selective antagonist at cloned human D4 receptors.

  1997cited by this paper
• 3-((4-(4-Chlorophenyl)piperazin-1-yl)-methyl)-1H-pyrrolo-2,3-b-pyridine: an antagonist with high affinity and selectivity for the human dopamine D4 receptor.

  1996cited by this paper
• The naphtosultam derivative RP 62203 (fananserin) has high affinity for the dopamine D4 receptor.

  1996cited by this paper
• D4 receptors and their antagonists

  1996cited by this paper
• (S)-(-)-4-[4-[2-(isochroman-1-yl)ethyl]-piperazin-1-yl] benzenesulfonamide, a selective dopamine D4 antagonist.

  1996cited by this paper
• Full-length cDNA cloning and distribution of human dopamine D4 receptor.

  1995cited by this paper
• Dopamine receptor pharmacology.

  1994cited by this paper
• Dopamine D4 receptors elevated in schizophrenia

  1993cited by this paper
• Positron emission tomographic analysis of central D1 and D2 dopamine receptor occupancy in patients treated with classical neuroleptics and clozapine. Relation to extrapyramidal side effects.

  1992cited by this paper
• Dopamine receptor sequences. Therapeutic levels of neuroleptics occupy D2 receptors, clozapine occupies D4.

  1992cited by this paper
• Tardive dyskinesia: summary of a Task Force Report of the American Psychiatric Association. By the Task Force on Late Neurological Effects of Antipsychotic Drugs.

  1980cited by this paper

• Arene Amination Instead of Fluorination: Substitution Pattern Governs the Reactivity of Dialkoxybenzenes with Selectfluor.

  2021cites this paper
• Enantioselective Synthesis of 3‐Fluorochromanes via I(I)/I(III) Catalysis

  2020cites this paper
• Enantioselective Synthesis of 3‐Fluorochromanes via Iodine(I)/Iodine(III) Catalysis

  2020cites this paper
• Molecular pharmacophore selectivity studies, virtual screening, and in silico ADMET analysis of GPCR antagonists

  2015cites this paper
• [(1,3-Bis{2,6-bis(diphenylmethyl)-4-methylphenyl}imidazole-2-ylidene)PdCl2(NEt3)]: “Throwing away” a different ancillary ligand to enhance the catalytic activity at room temperature

  2014cites this paper
• Labeling of benzodioxin piperazines with fluorine-18 as prospective radioligands for selective imaging of dopamine D4 receptors.

  2013cites this paper
• Single-nucleotide evolution quantifies the importance of each site along the structure of mitochondrial carriers

  2013cites this paper
• Update 1 of: Recent progress in development of dopamine receptor subtype-selective agents: potential therapeutics for neurological and psychiatric disorders.

  2013cites this paper
• Evaluation of 18F-labeled benzodioxine piperazine-based dopamine D4 receptor ligands: lipophilicity as a determinate of nonspecific binding.

  2011cites this paper
• Synthesis of 3-(5-bromo-2,3-dimethoxy-phenyl)-[1, 2, 4] oxadiazole analogues and their evaluation as anti-Parkinson′s agents

  2008cites this paper
• Exploring structure–selectivity relationships of biogenic amine GPCR antagonists using similarity searching and dynamic compound mapping

  2008cites this paper
• Benzo‐fused heterocycles and carbocycles by intramolecular SNAr and tandem SN2‐SNAr reactions

  2008cites this paper
• Experimental and computational thermochemistry of 1,4-benzodioxan and its 6-R derivatives.

  2008cites this paper
• Recent progress in development of dopamine receptor subtype-selective agents: potential therapeutics for neurological and psychiatric disorders.

  2007cites this paper
• Indolebutylamines as selective 5-HT(1A) agonists.

  2004cites this paper
• Synthesis of annulated dioxins as electron-rich donors for cation radical salts

  2004cites this paper
• 1H-Pyrazolo-[3,4-c]cyclophepta[1,2-c]thiophenes: a unique structural class of dopamine D4 selective ligands.

  2003cites this paper
• Indoline and piperazine containing derivatives as a novel class of mixed D(2)/D(4) receptor antagonists. Part 1: identification and structure-activity relationships.

  2002cites this paper